On November 22, Beijing Qinghui Liannuo Biotechnology co., Ltd. (“Qinghui Liannuo”) announced its completion of 100-million-yuan pre-A round of financing. 

This round was jointly funded by ZGC Collaborative Innovation Funds, Longpan Investment and Honghui Capital. The funds will be used in clinical trial of allogeneic cell drug products, preclinical research of innovative targeted drugs, and the construction of a R&D center.